Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Clinical Microbiology and Infectious Diseases Année : 2019
Fichier non déposé

Dates et versions

hal-04325265 , version 1 (05-12-2023)

Identifiants

Citer

Benoît Pilmis, Grégoire Petitjean, Philippe Lesprit, Matthieu Lafaurie, Najoua El Helali, et al.. Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa. European Journal of Clinical Microbiology and Infectious Diseases, 2019, 38 (8), pp.1457-1461. ⟨10.1007/s10096-019-03573-4⟩. ⟨hal-04325265⟩
3 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More